Fulvic & Humic Minerals Research — The Complete Study Library
Fulvic & Humic Minerals Research — The Complete Study Library
We believe in showing our work. Every benefit statement on this website is grounded in published, peer-reviewed research on fulvic acid, humic acid, and the specific nutrients in our formulas. This page is our complete study library — organized by topic, with study types, key findings, and direct links to every source.
The research on this page examines fulvic acid, humic acid, and related compounds as naturally occurring substances. These studies do not examine Vital Earth Minerals products specifically. Research is cited for educational purposes only.
These statements have not been evaluated by the Food and Drug Administration. Vital Earth Minerals products are not intended to diagnose, treat, cure, or prevent any disease. Studies cited on this page do not constitute evidence that any Vital Earth Minerals product treats, prevents, cures, or diagnoses any disease or condition. Consult a qualified healthcare professional for personal health guidance.
How to Read This Page
Not all research is equal. The leaf badge on each study shows how much weight to give the evidence — three leaves for the strongest, one for the earliest-stage. Each study also names its type so you can judge it yourself:
| Study type | What it means | Evidence strength |
|---|---|---|
| In vitro (cell study) | Observed in cells in a laboratory — not in a living organism | Early-stage. Cannot be directly applied to human outcomes. |
| In vivo (animal study) | Observed in animals — closer to human biology but not equivalent | Moderate. Informative but not conclusive for humans. |
| Human observational | Observed in humans without controlled conditions | Relevant but subject to confounding factors. |
| Retrospective chart review | Observed by reviewing existing medical records | Real-world data but lacks controlled experimental design. |
| Randomized controlled trial (RCT) | Participants randomly assigned to treatment or control — gold standard | Highest evidence level for clinical claims. |
| Systematic review / Meta-analysis | Summarizes and analyzes multiple existing studies | High evidence level for the overall body of literature. |
Gut Microbiome & Digestive Health
7 studies. Products: Fulvic Minerals, Humic Minerals, Super Strength Humic, Mineral Blend, Fulvic Minerals for Animals.
Rudnicka K et al. (2026)
Scientific Reports (Nature Publishing Group), Vol. 16:6166
Tier 1 · Strong
Study type: Randomized controlled study — in vivo and cellular assay
Key finding: Alkaline fulvic acid stimulated beneficial Lactobacillus bacteria up to 600% and significantly reduced Helicobacter and Campylobacter pathogenic strains in vivo (p<0.05). Superior cytocompatibility over acidic fulvic formulations. Wound healing scratch assay documented sustained intestinal cell regeneration at 24h, 48h, and 72h.
Products: Fulvic Minerals, Mineral Blend, Super Strength Humic, Fulvic Mineral Mist
Huang J et al. (2023)
Frontiers in Microbiology, Vol. 14:1147110
Tier 1 · Strong
Study type: In vivo study
Key finding: Humic acids increased beneficial Lactobacillus and Bifidobacterium populations, reduced pro-inflammatory cytokines TNF-α and IL-6 via TLR4/NF-kB pathway, supported tight junction protein expression including occludin and claudin-1, maintaining gut barrier integrity.
Products: Humic Minerals, Super Strength Humic, Mineral Blend, Fulvic Minerals for Animals
Móritz AV et al. (2026)
Animals MDPI Vol. 16(2):173
Tier 3 · Emerging
Study type: In vitro study (intestinal cell and canine immune cell models)
Key finding: A humic acid supplement preserved intestinal barrier integrity in an intestinal cell model and reduced LPS-induced pro-inflammatory cytokines (TNF-α, IL-6) in canine immune cells. Short-chain fatty acid production was not measured in this study.
Products: Humic Minerals, Super Strength Humic, Mineral Blend, Fulvic Minerals for Animals
He Y et al. (2023)
Molecular Immunology Vol. 161:61-73
Tier 2 · Moderate
Study type: In vivo study
Key finding: Alkaline sodium humate alleviated intestinal barrier injury, enhanced expression of tight junction proteins, and regulated gut microbiota composition.
Products: Humic Minerals, Super Strength Humic, Mineral Blend
Winkler J, Ghosh S (2018)
Journal of Diabetes Research, PMC6151376
Tier 2 · Moderate
Study type: Peer-reviewed mini-review (synthesis of existing research)
Key finding: Highly cited foundational review. Fulvic acid modulates immune system, oxidative state, and GI function. Clinical data on oxifulvic acid (4.5%) reducing allergen-challenge responses in humans. Documents digestive enzyme activity support including lysozyme, proteases, and phosphatases.
Products: All oral products
Feng P et al. (2022)
Frontiers in Nutrition Vol. 9:963271, PMC9389313
Tier 3 · Emerging
Study type: In vivo animal study (poultry)
Key finding: Fulvic acid modulated gut microbiota composition, reduced TNF-α, and increased IL-2 in poultry model.
Products: Fulvic Minerals, Mineral Blend, Fulvic Minerals for Animals
Xiao G et al. (2022)
Frontiers in Veterinary Science Vol. 9:953564, PMC9479332
Tier 3 · Emerging
Study type: In vivo animal study (poultry)
Key finding: Fulvic acid supplementation improved gut microbiota diversity and reduced oxidative stress in aged poultry. Most directly relevant published veterinary study for animal mineral supplementation.
Products: Fulvic Minerals for Animals, Fulvic Minerals
Immune Function & Anti-Inflammatory Activity
3 studies. Products: All oral products.
Gvozdeva Y et al. (2025)
Antioxidants MDPI, PMC12466450, Vol. 14(9):1139
Tier 1 · Strong
Study type: 111-reference comprehensive review
Key finding: Most comprehensive recent review: 111 references covering antioxidant, anti-inflammatory, antimicrobial, antiviral, immunomodulatory, wound healing, gut microbiota, and anticancer properties. Quinone groups identified as drivers of bactericidal effects.
Products: All oral products
Zykova MV et al. (2025)
Molecules MDPI Vol. 31(1):114
Tier 1 · Strong
Study type: Comprehensive peer-reviewed review
Key finding: Comprehensive pharmacological review documenting immunotropic, antibacterial, antiviral, antitumor, antioxidant, cardiotropic, hepatoprotective, regenerative, detoxifying, and adaptogenic effects of humic substances. Full NF-kB/TLR signaling mechanisms documented.
Products: All oral products
van Rensburg CEJ (2015)
Phytotherapy Research Vol. 29(6):791-795
Tier 2 · Moderate
Study type: Peer-reviewed review
Key finding: Potassium humate inhibits pro-inflammatory cytokines, adhesion molecules, oxidants, and complement activation.
Products: Humic Minerals, Super Strength Humic, Mineral Blend, Vital Joint Support
Antioxidant Activity, Energy & Cellular Function
3 studies. Products: All oral products; Fulvic Mineral Mist.
Klein OI et al. (2021)
Polymers MDPI Vol. 13(19):3262, PMC8512611
Tier 2 · Moderate
Study type: Laboratory analytical study
Key finding: Analysis of 25 humic substance samples: antioxidant capacity of 0.31–2.56 μmol Trolox equivalents per mg, close to values for vitamin C and vitamin E. Phenolic and non-phenolic structural groups both contributed to antioxidant activity.
Products: All oral products
Keller JL et al. (2019)
Journal of the International Society of Sports Nutrition, Vol. 16:3, PMC6364418
Tier 2 · Moderate
Study type: Randomized, placebo-controlled trial (human), 8 weeks
Key finding: Shilajit, a natural substance rich in fulvic acid, taken at 500 mg per day for 8 weeks helped participants retain more maximal muscle strength after a fatiguing exercise protocol than placebo (8.9% decline vs. 16.0%), and lowered a marker of collagen breakdown (hydroxyproline). Results apply to shilajit, not fulvic acid alone.
Products: Fulvic Minerals, Mineral Blend, Super Strength Humic, Super Multi
Swat M et al. (2019)
Foods MDPI, PMC6963745
Tier 2 · Moderate
Study type: Laboratory characterization study
Key finding: Direct laboratory characterization confirming 70+ ionic trace minerals in liquid fulvic acid beverages. Fulvic acid demonstrated improved bioavailability of co-administered compounds. ORAC antioxidant capacity measured. Directly examines liquid fulvic acid beverages — same format as Vital Earth products.
Products: All oral products
Skin Health & Topical Applications
4 studies. Products: Fulvic Mineral Mist (primary); Fulvic Minerals (secondary).
Rudnicka K et al. (2026) — Cellular Regeneration Assay
Scientific Reports (Nature Publishing Group), Vol. 16:6166
Tier 1 · Strong
Study type: Cellular regeneration assay
Key finding: Alkaline fulvic formulation (MLG-A50) showed the most pronounced and sustained pro-regenerative effect in wound healing scratch assay at 24h, 48h, and 72h. Significantly outperformed acidic fulvic formulations and purified fulvic acid standards.
Products: Fulvic Mineral Mist
Kinoshita H et al. (2012) — Keio University
Nishinihon Journal of Dermatology, Vol. 74(4):427-431
Tier 1 · Strong
Study type: In vitro study
Key finding: 1% fulvic acid increased fibroblast viability by 26.1%. Fulvic acid inhibited collagen-degrading MMP-8 enzyme by 47–61% (p<0.01). Strongest collagen matrix substantiation finding in the research library.
Products: Fulvic Mineral Mist
Gheibi N et al. (2024)
Journal of Cutaneous and Aesthetic Surgery, Vol. 17(2):105-111
Tier 2 · Moderate
Study type: In vivo animal model
Key finding: Combined topical fulvic and humic acid promoted tissue re-epithelialization (skin cell renewal) and supported normal tissue regeneration.
Products: Fulvic Mineral Mist
CHD-FvA Randomized Clinical Trial (referenced in Winkler & Ghosh 2018)
Referenced in PMC6151376
Tier 2 · Moderate
Study type: Randomized controlled trial (human) — topical application
Key finding: Randomized clinical trial of carbohydrate-derived fulvic acid (CHD-FvA) topical application: statistically significant improvements in skin health measures. Oxifulvic acid (4.5%) reduced allergen-challenge wheal and flare response, comparable to 1% hydrocortisone in referenced comparison.
Products: Fulvic Mineral Mist
Note: CHD-FvA is carbohydrate-derived, which may differ from plant-derived humate fulvic acid.
Cognitive Function & Neuroprotection
1 study. Animal model only. Products: Humic Minerals, Super Strength Humic, Super Multi.
Omolaso BO et al. (2024)
Nutrire Vol. 49:46
Tier 3 · Emerging
Study type: In vivo animal study
Key finding: In rats with chemically induced colitis, humic acid reduced anxiety-like and depression-like behavior and cognitive impairment, alongside changes in brain antioxidant enzymes, inflammatory markers, and neurochemicals. Animal model only — human research on humic acid and brain function is limited.
Products: Humic Minerals, Super Strength Humic, Super Multi
Safety, Bioavailability & Toxicology
2 studies. Applies to all products. Essential regulatory references.
Murbach TS et al. (2020)
Toxicology Reports Vol. 7:1242–1254
Tier 1 · Strong
Study type: Formal safety and toxicology study (human)
Key finding: Formal safety and tolerability evaluation. Favorable safety profile confirmed — no evidence of systemic toxicity across multiple endpoints including genotoxicity, clinical chemistry, hematology, and urinalysis. Essential regulatory reference for all Vital Earth Minerals products.
Products: All products — regulatory substantiation
Hricikova S et al. (2023)
Foods MDPI, PMC10142745
Tier 2 · Moderate
Study type: 20-year narrative review
Key finding: 20-year narrative review covering human health effects, animal studies, commercial humate products, safety profile, anti-inflammatory activity, absorbent properties, and microbiome applications.
Products: All products
Calcium, Magnesium & Bone Health
4 studies. Products: Cal-Mag Liquid.
DSHEA note: Use structure/function language only. Claim “supports normal bone density maintenance” — do not claim fracture reduction, treatment of osteoporosis, or any disease-specific outcome.
Cong B, Zhang H (2025)
BMC Musculoskeletal Disorders Vol. 26:928, PMC12506016
Tier 2 · Moderate
Study type: Systematic review and meta-analysis of RCTs
Key finding: In postmenopausal women with low bone density, combined calcium and vitamin D modestly improved pelvic bone mineral density and corrected low vitamin D levels. No significant change was seen at the spine or hip.
Products: Cal-Mag Liquid
Note: Fracture reduction is a disease-specific outcome. Used only for the normal bone density maintenance structure/function claim.
Xie C et al. (2024)
Bone & Joint Research Vol. 13(12):750-763, PMC11631259
Tier 2 · Moderate
Study type: Meta-analysis of RCTs
Key finding: In middle-aged and older adults, vitamin K supplementation (especially K2) helped maintain or increase lumbar spine bone mineral density, with the clearest effect in women. Its main action was improving the carboxylation (activation) of osteocalcin, the protein that binds calcium into bone.
Products: Cal-Mag Liquid
Aaseth JO et al. (2024)
Nutrients MDPI, Vol. 16(15):2420, PMC11313760
Tier 2 · Moderate
Study type: Peer-reviewed review
Key finding: D3 increases calcium absorption and stimulates vitamin K-dependent proteins including osteocalcin and Matrix Gla Protein (MGP). K2 directs calcium to bones and away from arterial walls and soft tissue. MK-7 shows higher bioavailability than MK-4.
Products: Cal-Mag Liquid
Friling M et al. (2023)
Frontiers in Nutrition, PMC10050718
Tier 2 · Moderate
Study type: Randomized crossover study (human)
Key finding: Randomized crossover study (24 participants): calcium citrate showed favorable absorption profile. Pre-acidified liquid calcium citrate form supports ready absorption without requiring stomach acid for conversion.
Products: Cal-Mag Liquid
Joint Health & Connective Tissue
4 studies. Products: Vital Joint Support.
DSHEA note: Use structure/function language only. Claim “supports normal joint comfort and healthy cartilage” — do not claim treatment of arthritis, osteoarthritis, pain reduction, or any disease-specific outcome.
Baden KR et al. (2025) — Cedarville University
Nutrients MDPI Vol. 17(13):2093, PMC12250884
Tier 1 · Strong
Study type: PRISMA systematic review
Key finding: More than 90% of efficacy studies reported positive outcomes for glucosamine and chondroitin. Glucosamine inhibits MMPs and aggrecanases that degrade cartilage. Chondroitin decreases collagenolytic activity and induces proteoglycan production. Minimal adverse effects across studies.
Products: Vital Joint Support
Sumsuzzman DM et al. (2024)
Journal of Clinical Medicine Vol. 13(23):7444, PMC11641979
Tier 2 · Moderate
Study type: Systematic review and network meta-analysis of 30 RCTs
Key finding: Network meta-analysis of 30 randomized controlled trials (5,265 participants) comparing glucosamine-based combinations. The glucosamine + chondroitin + MSM combination outperformed placebo on joint comfort outcomes (low-quality evidence).
Products: Vital Joint Support
Wang B et al. (2025)
Frontiers in Nutrition, PMC12754907
Tier 2 · Moderate
Study type: Clinical trials review
Key finding: Clinical trials: oral hyaluronic acid significantly decreased WOMAC scores for stiffness and physical function measures. Animal models documented reduced arthritis progression and cartilage damage. Hyaluronic acid supports normal joint lubrication and synovial fluid function.
Products: Vital Joint Support
Meng Z et al. (2023)
Archives of Orthopaedic and Trauma Surgery Vol. 143(1):409-421
Tier 2 · Moderate
Study type: Meta-analysis
Key finding: Anti-inflammatory and cartilage-preserving properties of glucosamine/chondroitin combination confirmed. The combination showed benefit vs. placebo in joint function outcomes.
Products: Vital Joint Support
Methylated B Vitamins & MTHFR Support
4 studies. Products: Super Multi Liquid Vitamins.
Pokushalov E et al. (2024)
Nutrients MDPI Vol. 16(11):1550, PMC11173557
Tier 1 · Strong
Study type: Randomized double-blind placebo-controlled trial (human)
Key finding: Randomized double-blind placebo-controlled trial (54 patients, 6 months): Methylfolate + Pyridoxal-5-Phosphate (P5P) + Methylcobalamin combination tailored to MTHFR genetic profiles effectively supported normal homocysteine metabolism.
Products: Super Multi Liquid Vitamins
Kataria N et al. (2021)
Cureus, PMC8191525
Tier 2 · Moderate
Study type: Meta-analysis of RCTs
Key finding: Meta-analysis: B6 + B9 + B12 supplementation supports normal homocysteine metabolism and normal cardiovascular function.
Products: Super Multi Liquid Vitamins
NIH Office of Dietary Supplements
Riboflavin: Fact Sheet for Health Professionals
Tier 1 · Strong
Study type: NIH regulatory reference
Key finding: Riboflavin (vitamin B2) is a major component of the coenzymes FAD and FMN, which play major roles in energy production and cellular function. An established Daily Value exists for riboflavin.
Products: Super Multi Liquid Vitamins
Nazki FH et al. (2014)
Gene Vol. 533(1):11-20
Tier 2 · Moderate
Study type: Peer-reviewed review
Key finding: Review of MTHFR gene variant prevalence. Documents widespread prevalence of C677T and A1298C variants and their effects on folate metabolism. Estimated 40–60% of adults carry at least one significant MTHFR variant.
Products: Super Multi Liquid Vitamins
Landmark & Foundational Reviews
3 studies. Apply to all products as master references.
Gvozdeva Y et al. (2025)
Antioxidants MDPI, PMC12466450, September 2025
Tier 1 · Strong
Study type: 111-reference comprehensive review
Key finding: Most comprehensive recent review of humic substance biomedical applications: 111 references covering antioxidant, anti-inflammatory, antimicrobial, antiviral, immunomodulatory, wound healing, gut microbiota, and anticancer properties.
Products: All oral products — master reference
Zykova MV et al. (2025)
Molecules MDPI Vol. 31(1):114, December 2025
Tier 1 · Strong
Study type: Comprehensive peer-reviewed review
Key finding: Comprehensive pharmacological review: immunotropic, antibacterial, antiviral, antitumor, antioxidant, cardiotropic, hepatoprotective, regenerative, detoxifying, and adaptogenic effects documented with full NF-kB/TLR signaling mechanisms.
Products: All oral products — master reference
Hricikova S et al. (2023)
Foods MDPI, PMC10142745
Tier 2 · Moderate
Study type: 20-year narrative review
Key finding: 20-year narrative review: human health effects, animal studies, commercial humate products, anti-inflammatory activity, absorbent properties, and microbiome applications.
Products: All oral products
Oncology Research — Early-Stage Laboratory Only
2 studies. Cited for scientific completeness. Not referenced in product marketing.
These studies are cited for scientific completeness only. They are early-stage laboratory research and do not constitute evidence that any Vital Earth Minerals product treats, prevents, cures, or diagnoses cancer. They are never referenced in product marketing, product descriptions, email campaigns, or any consumer-facing content other than this study library.
Gulcicek A et al. (2024)
European Journal of Cancer Care, DOI 10.1155/2024/5871444
Handle with care
Study type: In vivo animal study (mouse model) — early-stage laboratory research
Key finding: In vivo mouse model (SCID mice, MCF-7 breast cancer cell line). Fulvic acid associated with reduced tumor formation in the animal model. Results in mouse models do not reliably predict results in humans.
Products: Research library reference only — never in product marketing
Note: Early-stage laboratory research in an animal model. Does not indicate that Vital Earth Minerals products treat, prevent, or cure breast cancer or any cancer in humans.
Chen M et al. (2025)
Discover Oncology Vol. 16:523, PMC11993516
Handle with care
Study type: In vitro cell study (laboratory) — early-stage laboratory research
Key finding: In vitro observations of fulvic acid effects on ovarian cancer cell lines in laboratory conditions. Cell culture studies represent the earliest stage of oncology research.
Products: Research library reference only — never in product marketing
Note: In vitro cell studies do not translate directly to human outcomes. Does not indicate that Vital Earth Minerals products treat, prevent, or cure ovarian cancer or any cancer in humans.
Where More Research Is Needed
Being transparent about the limits of current evidence is as important as documenting what exists:
- Large-scale human randomized controlled trials across all primary health areas — gut health, immune function, energy, and bone health.
- Long-term supplementation studies examining outcomes over months to years in human subjects.
- Standardized preparations — different studies use different preparations (source, concentration, extraction method), making direct comparison difficult.
- Comparative studies between plant-derived and rock-derived fulvic acid preparations in human subjects.
- Human clinical confirmation of the specific cellular mechanisms that are well-characterized in in vitro and animal research.
Ongoing Research Areas to Watch
- Gut microbiome modulation: human microbiome research is expanding rapidly. Fulvic and humic acid prebiotic effects are an active area.
- Antiviral properties: research examining humic acid’s interaction with viral proteins continues.
- Metabolic health: research examining fulvic acid in the context of blood sugar regulation and metabolic function.
- Neuroprotection: early-stage research examining fulvic acid’s potential relevance to brain health and cognitive function.
- Skin health: growing body of research on topical mineral applications and cellular regeneration.
These statements have not been evaluated by the Food and Drug Administration. Vital Earth Minerals products are not intended to diagnose, treat, cure, or prevent any disease. The studies cited on this page are for educational purposes only and do not constitute evidence that Vital Earth Minerals products treat, prevent, cure, or diagnose any disease or condition. Consult a qualified healthcare professional for personal health guidance.
Research library last updated: October 2026 | vitalearthminerals.com/research